Alice S. Mims, MD, on AML: Updates on Managing Newly Diagnosed Disease

November 09, 2021 By The ASCO Post Staff

Alice S. Mims, MD, of The Ohio State University Comprehensive Cancer Center, discusses the many positive changes over the past 5 years in treating patients with newly diagnosed acute myeloid leukemia in the upfront setting. She also details future directions, including further combining therapies with targeted agents, the potential use of all-oral regimens, and using measurable residual disease as a possible endpoint in treatment responses.

Related Content